Delivery Order SPE2DB22D3501-SPE2DB26FTK99
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,379.83 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 23, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,817.34 on August 19, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams). This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, valued at $11,581.53. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,633.78 on November 5, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 gram units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of November 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,169.18 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalant medication (12 gram units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a $1,817.31 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine medical supply procurement under AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK99Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,301.76 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12-gram containers). This contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal agencies. The underlying IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/6/25 |